{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:53:50Z","timestamp":1786982030033,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 105-2314-B-038-006"],"award-info":[{"award-number":["MOST 105-2314-B-038-006"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2628-B-038-008-MY2"],"award-info":[{"award-number":["NSTC 112-2628-B-038-008-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11695-025-08450-y","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:25:39Z","timestamp":1767032739000},"page":"652-665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum Lipidome as a Predictor of Significant Liver Fibrosis in Patients with Severe Obesity Undergoing Bariatric Surgery"],"prefix":"10.1007","volume":"36","author":[{"given":"Chien-Hung","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ru","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Wen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binar","family":"Panunggal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yu","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"6","key":"8450_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386.","journal-title":"Hepatology"},{"issue":"3","key":"8450_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7861\/clinmedicine.19-3-205","volume":"19","author":"A Ruban","year":"2019","unstructured":"Ruban A, Stoenchev K, Ashrafian H, Teare J. Current treatments for obesity. Clin Med (Lond). 2019;19(3):205\u201312.","journal-title":"Clin Med (Lond)"},{"issue":"9","key":"8450_CR3","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","volume":"107","author":"KE Chan","year":"2022","unstructured":"Chan KE, Koh TJL, Tang ASP, et al. Global prevalence and clinical characteristics of Metabolic-associated fatty liver disease: A Meta-Analysis and systematic review of 10 739 607 individuals. J Clin Endocrinol Metab. 2022;107(9):2691\u2013700.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"8450_CR4","doi-asserted-by":"publisher","first-page":"e13481","DOI":"10.1111\/obr.13481","volume":"23","author":"W Theel","year":"2022","unstructured":"Theel W, Boxma-de Klerk BM, Dirksmeier-Harinck F, et al. Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques. Obes Rev. 2022;23(8):e13481.","journal-title":"Obes Rev"},{"issue":"4","key":"8450_CR5","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347.","journal-title":"Hepatology"},{"issue":"5","key":"8450_CR6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M, Hagstr\u00f6m H, Nasr P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61(5):1547\u201354.","journal-title":"Hepatology"},{"issue":"11","key":"8450_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nrgastro.2013.175","volume":"10","author":"L Castera","year":"2013","unstructured":"Castera L, Vilgrain V, Angulo P. Noninvasive evaluation of NAFLD. Nat Rev Gastroenterol Hepatol. 2013;10(11):666\u201375.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"8450_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/cld.740","volume":"13","author":"D Berger","year":"2019","unstructured":"Berger D, Desai V, Janardhan S, Con. Liver biopsy remains the gold standard to evaluate fibrosis in patients with nonalcoholic fatty liver disease. Clin Liver Dis (Hoboken). 2019;13(4):114\u20136.","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"4","key":"8450_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2021.04.044","volume":"75","author":"EA Selvaraj","year":"2021","unstructured":"Selvaraj EA, M\u00f3zes FE, Jayaswal ANA, et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. J Hepatol. 2021;75(4):770\u201385.","journal-title":"J Hepatol"},{"key":"8450_CR10","doi-asserted-by":"crossref","unstructured":"Andersen OS, Koeppe RE 2nd. Bilayer thickness and membrane protein function: an energetic perspective. Annu Rev Biophys Biomol Struct. 2007;36:107\u201330.","DOI":"10.1146\/annurev.biophys.36.040306.132643"},{"issue":"2","key":"8450_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nrm2335","volume":"9","author":"MP Wymann","year":"2008","unstructured":"Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol. 2008;9(2):162\u201376.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"8450_CR12","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41419-022-05263-0","volume":"13","author":"CT Mannully","year":"2022","unstructured":"Mannully CT, Bruck-Haimson R, Zacharia A, et al. Lipid desaturation regulates the balance between self-renewal and differentiation in mouse blastocyst-derived stem cells. Cell Death Dis. 2022;13(12):1027.","journal-title":"Cell Death Dis"},{"issue":"1","key":"8450_CR13","doi-asserted-by":"publisher","first-page":"e1466","DOI":"10.1002\/wsbm.1466","volume":"12","author":"VB O\u2019Donnell","year":"2020","unstructured":"O\u2019Donnell VB, Ekroos K, Liebisch G, Wakelam M, Lipidomics. Current state of the Art in a fast moving field. Wiley Interdiscip Rev Syst Biol Med. 2020;12(1):e1466.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"11","key":"8450_CR14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.tibs.2016.08.010","volume":"41","author":"K Yang","year":"2016","unstructured":"Yang K, Han X, Lipidomics. Techniques, Applications, and outcomes related to biomedical sciences. Trends Biochem Sci. 2016;41(11):954\u201369.","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"8450_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s42979-021-00592-x","volume":"2","author":"IH Sarker","year":"2021","unstructured":"Sarker IH. Machine learning: Algorithms, Real-World applications and research directions. SN Comput Sci. 2021;2(3):160.","journal-title":"SN Comput Sci"},{"issue":"3","key":"8450_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/jgh.15415","volume":"36","author":"TH Su","year":"2021","unstructured":"Su TH, Wu CH, Kao JH. Artificial intelligence in precision medicine in hepatology. J Gastroenterol Hepatol. 2021;36(3):569\u201380.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"8450_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1677\/JME-08-0150","volume":"42","author":"T Sepp\u00e4nen-Laakso","year":"2009","unstructured":"Sepp\u00e4nen-Laakso T, Oresic M. How to study lipidomes. J Mol Endocrinol. 2009;42(3):185\u201390.","journal-title":"J Mol Endocrinol"},{"issue":"5","key":"8450_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s11695-012-0610-7","volume":"22","author":"K Kasama","year":"2012","unstructured":"Kasama K, Mui W, Lee WJ, et al. IFSO-APC consensus statements 2011. Obes Surg. 2012;22(5):677\u201384.","journal-title":"Obes Surg"},{"issue":"5","key":"8450_CR19","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/hep.25889","volume":"56","author":"P Bedossa","year":"2012","unstructured":"Bedossa P, Poitou C, Veyrie N, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 2012;56(5):1751\u20139.","journal-title":"Hepatology"},{"issue":"12","key":"8450_CR20","doi-asserted-by":"publisher","first-page":"165538","DOI":"10.1016\/j.bbadis.2019.165538","volume":"1865","author":"AF Anzmann","year":"2019","unstructured":"Anzmann AF, Pinto S, Busa V, et al. Multi-omics studies in cellular models of methylmalonic acidemia and propionic acidemia reveal dysregulation of Serine metabolism. Biochim Biophys Acta Mol Basis Dis. 2019;1865(12):165538.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"11","key":"8450_CR21","doi-asserted-by":"publisher","first-page":"e70056","DOI":"10.1111\/cts.70056","volume":"17","author":"AV Ponce-Bobadilla","year":"2024","unstructured":"Ponce-Bobadilla AV, Schmitt V, Maier CS, Mensing S, Stodtmann S. Practical guide to SHAP analysis: explaining supervised machine learning model predictions in drug development. Clin Transl Sci. 2024;17(11):e70056.","journal-title":"Clin Transl Sci"},{"issue":"2","key":"8450_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","volume":"103","author":"JK Dowman","year":"2010","unstructured":"Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM. 2010;103(2):71\u201383.","journal-title":"QJM"},{"issue":"8","key":"8450_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4254\/wjh.v12.i8.436","volume":"12","author":"S Kartsoli","year":"2020","unstructured":"Kartsoli S, Kostara CE, Tsimihodimos V, Bairaktari ET, Christodoulou DK. Lipidomics in non-alcoholic fatty liver disease. World J Hepatol. 2020;12(8):436\u201350.","journal-title":"World J Hepatol"},{"issue":"3","key":"8450_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jhep.2021.04.013","volume":"75","author":"GJ Ooi","year":"2021","unstructured":"Ooi GJ, Meikle PJ, Huynh K, et al. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis. J Hepatol. 2021;75(3):524\u201335.","journal-title":"J Hepatol"},{"issue":"1","key":"8450_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12944-024-02380-x","volume":"23","author":"CJF Heymann","year":"2024","unstructured":"Heymann CJF, Mak AL, Holleboom AG, et al. The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease. Lipids Health Dis. 2024;23(1):402.","journal-title":"Lipids Health Dis"},{"key":"8450_CR26","doi-asserted-by":"publisher","first-page":"175628482092390","DOI":"10.1177\/1756284820923904","volume":"13","author":"C Caussy","year":"2020","unstructured":"Caussy C, Chuang JC, Billin A, et al. Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis. Th Adv Gastroenterol. 2020;13:1756284820923904.","journal-title":"Th Adv Gastroenterol"},{"issue":"12","key":"8450_CR27","doi-asserted-by":"publisher","first-page":"e0189965","DOI":"10.1371\/journal.pone.0189965","volume":"12","author":"W Yoo","year":"2017","unstructured":"Yoo W, Gjuka D, Stevenson HL, et al. Fatty acids in non-alcoholic steatohepatitis: focus on Pentadecanoic acid. PLoS ONE. 2017;12(12):e0189965.","journal-title":"PLoS ONE"},{"key":"8450_CR28","doi-asserted-by":"publisher","first-page":"156063","DOI":"10.1016\/j.metabol.2024.156063","volume":"162","author":"S Muralidharan","year":"2025","unstructured":"Muralidharan S, Lee JWJ, Lim YS, et al. Serum lipidomic signatures in patients with varying histological severity of metabolic-dysfunction associated steatotic liver disease. Metabolism. 2025;162:156063.","journal-title":"Metabolism"},{"issue":"4","key":"8450_CR29","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.21763","volume":"46","author":"P Puri","year":"2007","unstructured":"Puri P, Baillie RA, Wiest MM, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46(4):1081\u201390.","journal-title":"Hepatology"},{"issue":"10","key":"8450_CR30","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1194\/jlr.M085613","volume":"59","author":"KY Peng","year":"2018","unstructured":"Peng KY, Watt MJ, Rensen S, et al. Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression. J Lipid Res. 2018;59(10):1977\u201386.","journal-title":"J Lipid Res"},{"issue":"10","key":"8450_CR31","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/apt.16066","volume":"52","author":"Y Jung","year":"2020","unstructured":"Jung Y, Lee MK, Puri P, et al. Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2020;52(10):1603\u201314.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"8450_CR32","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/hep.23719","volume":"52","author":"BA Neuschwander-Tetri","year":"2010","unstructured":"Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology. 2010;52(2):774\u201388.","journal-title":"Hepatology"},{"issue":"10","key":"8450_CR33","doi-asserted-by":"publisher","first-page":"109898","DOI":"10.4254\/wjh.v17.i10.109898","volume":"17","author":"SQ Li","year":"2025","unstructured":"Li SQ, Wu JH, Zhou Y, et al. Hepatocyte nuclear factors dynamically regulate triglyceride metabolic reprogramming in metabolic dysfunction-associated steatotic liver disease: mechanisms and implications. World J Hepatol. 2025;17(10):109898.","journal-title":"World J Hepatol"},{"issue":"6","key":"8450_CR34","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.21655","volume":"45","author":"K Yamaguchi","year":"2007","unstructured":"Yamaguchi K, Yang L, McCall S, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007;45(6):1366\u201374.","journal-title":"Hepatology"},{"issue":"4","key":"8450_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/sj.embor.7400378","volume":"6","author":"A Toker","year":"2005","unstructured":"Toker A. The biology and biochemistry of Diacylglycerol signalling. Meeting on molecular advances in Diacylglycerol signalling. EMBO Rep. 2005;6(4):310\u20134.","journal-title":"EMBO Rep"},{"issue":"1\u20132","key":"8450_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mam.2007.09.001","volume":"29","author":"M Nitti","year":"2008","unstructured":"Nitti M, Pronzato MA, Marinari UM, Domenicotti C. PKC signaling in oxidative hepatic damage. Mol Aspects Med. 2008;29(1\u20132):36\u201342.","journal-title":"Mol Aspects Med"},{"issue":"3","key":"8450_CR37","first-page":"172","volume":"2","author":"G Westenberger","year":"2021","unstructured":"Westenberger G, Sellers J, Fernando S, et al. Function of Mitogen-Activated protein kinases in hepatic inflammation. J Cell Signal. 2021;2(3):172\u201380.","journal-title":"J Cell Signal"},{"issue":"8","key":"8450_CR38","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1194\/jlr.M004796","volume":"51","author":"MA Kiebish","year":"2010","unstructured":"Kiebish MA, Bell R, Yang K, et al. Dynamic simulation of Cardiolipin remodeling: greasing the wheels for an interpretative approach to lipidomics. J Lipid Res. 2010;51(8):2153\u201370.","journal-title":"J Lipid Res"},{"issue":"12","key":"8450_CR39","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1089\/ars.2013.5280","volume":"20","author":"G Paradies","year":"2014","unstructured":"Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Cardiolipin and mitochondrial function in health and disease. Antioxid Redox Signal. 2014;20(12):1925\u201353.","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"8450_CR40","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","volume":"1859","author":"JN van der Veen","year":"2017","unstructured":"van der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Et Biophys Acta (BBA) - Biomembr. 2017;1859(9):1558\u201372. Part B).","journal-title":"Biochim Et Biophys Acta (BBA) - Biomembr"},{"issue":"5","key":"8450_CR41","doi-asserted-by":"publisher","first-page":"100477","DOI":"10.1016\/j.jhepr.2022.100477","volume":"4","author":"AJ McGlinchey","year":"2022","unstructured":"McGlinchey AJ, Govaere O, Geng D, et al. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease. JHEP Rep. 2022;4(5):100477.","journal-title":"JHEP Rep"},{"issue":"5","key":"8450_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41573-022-00582-5","volume":"22","author":"JE Burke","year":"2023","unstructured":"Burke JE, Triscott J, Emerling BM, Hammond GRV. Beyond PI3Ks: targeting phosphoinositide kinases in disease. Nat Rev Drug Discov. 2023;22(5):357\u201386.","journal-title":"Nat Rev Drug Discov"},{"key":"8450_CR43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev.cellbio.14.1.231","volume":"14","author":"TF Martin","year":"1998","unstructured":"Martin TF. Phosphoinositide lipids as signaling molecules: common themes for signal transduction, cytoskeletal regulation, and membrane trafficking. Annu Rev Cell Dev Biol. 1998;14:231\u201364.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"8450_CR44","doi-asserted-by":"publisher","first-page":"46658","DOI":"10.1038\/srep46658","volume":"7","author":"F Chiappini","year":"2017","unstructured":"Chiappini F, Coilly A, Kadar H, et al. Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients. Sci Rep. 2017;7:46658.","journal-title":"Sci Rep"},{"key":"8450_CR45","doi-asserted-by":"crossref","unstructured":"Tiwari-Heckler S, Gan-Schreier H, Stremmel W, Chamulitrat W, Pathil A. Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors. Nutrients 2018;10(5):649.","DOI":"10.3390\/nu10050649"},{"key":"8450_CR46","doi-asserted-by":"crossref","unstructured":"Mouskeftara T, Kalopitas G, Liapikos T, Arvanitakis K, Germanidis G, Gika H. Predicting Non-Alcoholic steatohepatitis: A Lipidomics-Driven machine learning approach. Int J Mol Sci. 2024;25(11):5965.","DOI":"10.3390\/ijms25115965"},{"key":"8450_CR47","doi-asserted-by":"crossref","unstructured":"Wu HC, Hsieh YR, Wang W et al. Potential hepatic lipid markers associated with nonalcoholic steatohepatitis and fibrosis in morbid obesity patients. J Clin Med. 2023;12(11):3730.","DOI":"10.3390\/jcm12113730"},{"issue":"5","key":"8450_CR48","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/hep.23186","volume":"50","author":"G Son","year":"2009","unstructured":"Son G, Hines IN, Lindquist J, Schrum LW, Rippe RA. Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis. Hepatology. 2009;50(5):1512\u201323.","journal-title":"Hepatology"},{"key":"8450_CR49","doi-asserted-by":"publisher","first-page":"154005","DOI":"10.1016\/j.metabol.2019.154005","volume":"101","author":"N Perakakis","year":"2019","unstructured":"Perakakis N, Polyzos SA, Yazdani A, et al. Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study. Metabolism. 2019;101:154005.","journal-title":"Metabolism"},{"key":"8450_CR50","doi-asserted-by":"crossref","unstructured":"Dahabiyeh LA, Mujammami M, AlMalki RH et al. Lipids alterations associated with Metformin in healthy subjects: an investigation using mass spectrometry shotgun approach. Int J Mol Sci. 2022;23(19):11478.","DOI":"10.3390\/ijms231911478"},{"issue":"5","key":"8450_CR51","doi-asserted-by":"publisher","first-page":"100800","DOI":"10.1016\/j.jlr.2025.100800","volume":"66","author":"C Yi","year":"2025","unstructured":"Yi C, Huynh K, Schooneveldt Y, et al. Statin effects on the lipidome: predicting Statin usage and implications for cardiovascular risk prediction. J Lipid Res. 2025;66(5):100800.","journal-title":"J Lipid Res"},{"issue":"10","key":"8450_CR52","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2337\/db23-0972","volume":"73","author":"G Della Pepa","year":"2024","unstructured":"Della Pepa G, Patr\u00edcio BG, Carli F, et al. GLP-1 receptor agonist treatment improves fasting and postprandial lipidomic profiles independently of diabetes and weight loss. Diabetes. 2024;73(10):1605\u201314.","journal-title":"Diabetes"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08450-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-025-08450-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08450-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:20:39Z","timestamp":1772551239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-025-08450-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["8450"],"URL":"https:\/\/doi.org\/10.1007\/s11695-025-08450-y","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of each participating clinical institution. The study protocol was approved by the Institutional Review Board of Taipei Medical University (approval numbers: TMU\u2013JIRB No.: N201601029 and No.: N202002060). This trial was registered at ClinicalTrials.gov (identifier: NCT04059029).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written informed consent was obtained from all participants included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}